Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$252,475
+$216,373 QoQ
Shares Held
1,611
+334.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,214
of 1,603 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fairfield Financial Advisors, LTD holds $15,764,978 across 4 Drug Manufacturers - General names. NVS ranks #4 (1.6% of the industry book) .
All Filings in NVS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $252,475 | 1,611 | Shares | Sole | 2026-08-11 | |
| 2024-12-31 | $36,102 | 371 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $55,899 | 486 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $51,739 | 486 | Shares | Sole | 2024-08-09 | |
| 2023-12-31 | $54,725 | 542 | Shares | Sole | 2024-11-04 | |
| 2023-09-30 | $41,355 | 406 | Shares | Sole | 2024-11-04 | |
| 2023-06-30 | $40,969 | 406 | Shares | Sole | 2024-11-04 | |
| 2023-03-31 | $37,352 | 406 | Shares | Sole | 2024-11-04 | |
| 2022-12-31 | $36,832 | 406 | Shares | Sole | 2024-10-07 | |
| 2022-09-30 | $30,860 | 406 | Shares | Sole | 2024-10-07 | |
| 2022-06-30 | $34,319 | 406 | Shares | Sole | 2024-10-07 | |
| 2022-03-31 | $35,626 | 406 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||